Related references
Note: Only part of the references are listed.Immunosuppressive activities of adenosine in cancer
Bertrand Allard et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
CD73-adenosine: a next-generation target in immuno-oncology
David Allard et al.
IMMUNOTHERAPY (2016)
Dendritic cells and cancer immunotherapy
Kristen J. Radford et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer
Bertrand Allard et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Anti-CD73 therapy impairs tumor angiogenesis
Bertrand Allard et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Adenosine-a physiological or pathophysiological agent?
Bertil B. Fredholm
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis
Li Wang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states
Maria Serena Longhi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
V. Kumar
PURINERGIC SIGNALLING (2013)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
Raffaella Iannone et al.
NEOPLASIA (2013)
Disarming suppressor cells to improve immunotherapy
Theresa L. Whiteside
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
CD73-Deficient Mice Are Resistant to Carcinogenesis
John Stagg et al.
CANCER RESEARCH (2012)
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene et al.
CANCER RESEARCH (2012)
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
Bertrand Allard et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
Helene Pere et al.
ONCOIMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Trina J. Stewart et al.
CANCER AND METASTASIS REVIEWS (2011)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
Dendritic cells and immunity against cancer
K. Palucka et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Adenosine up-regulates vascular endothelial growth factor in human macrophages
Isabelle Ernens et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling
Francisco Ciruela et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Adenosine and Prostaglandin E2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology
Peter B. Ernst et al.
JOURNAL OF IMMUNOLOGY (2010)
A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
Akio Ohta et al.
JOURNAL OF IMMUNOLOGY (2009)
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
Michail V. Sitkovsky
TRENDS IN IMMUNOLOGY (2009)
Adenosine receptors in regulation of dendritic cell differentiation and function
Sergey V. Novitskiy et al.
BLOOD (2008)
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Michail V. Sitkovsky et al.
CLINICAL CANCER RESEARCH (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Host A2B adenosine receptors promote carcinoma growth
Sergey Ryzhov et al.
NEOPLASIA (2008)
RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion
Xiuling Zhi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Overexpression of Ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix
Ping Zhou et al.
CANCER BIOLOGY & THERAPY (2007)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?
MV Sitkovsky et al.
TRENDS IN IMMUNOLOGY (2005)
Adenosine A2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis
MC Montesinos et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A(2A) receptors
MV Sitkovsky et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Dendritic cells in tumor immunology and immunotherapy
CJ Turtle et al.
CURRENT DRUG TARGETS (2004)
Dendritic cell-based vaccines and therapies for cancer
T Tatsumi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
